1Wiley S R, Schooley K, Smolak P J, et al. Identification and characterization of a new member of the TNF family that induces apoptosis[J]. Immunity, 1995,3(3) :673 -682.
2Henning W, Axel B, Heiko S, et al, Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on bcl-2- or bcl-xL-overexpressing chemotherapy-resistant tumor cells[J]. Cancer Res, 2000,60(11): 3051-3057.
3Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling,biology, and potential for cancer therapy [ J ]. Cytokine Growth Factor, 2003,14 (3-4) : 337 - 348.
4Marion M, TRAIL-induced signaling and apoptosis [ J ]. Toxicol Lett, 2003,139 (2-3) : 89 -97,
5Mariapia A, Degli-Esposti, William C, et al. The novel receptor TRAIL-R4 induces NF-kB and protects against TRAIL-Mediated apoptosis, yet retains an incomplete death domain [ J ]. Immunity,1997,7(6) :813 - 820,
6David B, Brigitte Q, Bernard V, et al. Rel/NF-κB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by Up-regulating the TRAIL decoy receptor DcR1 [ J ]. J Bin Chem, 2001,276( 29 ) : 27322 - 27328.
7Xufeng C, Karthikeyan K, Rakesh K, et al. Differential roles of RelA ( p65 ) and c-Rel subunits of nuclear factor KB in tumor necrosis factor-related apoptosis-inducing ligand signaling[J]. Cancer Res ,2003,63 ( 5 ) : 1059 - 1066.
8Pascal S, Margot T, Kim B, et al. TRAIL Receptors 1 (DR4)and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB [ J ]. Immunity, 1997 ( 6 ) ,7 : 831 - 836.
9Nicholas H, Stuart N, Allard K, et al. Modulation of tumor necrosis factor apoptosis-inducing ligand-induced NF-κB activation by inhibition of apical caspases [ J ]. J Bio Chem, 2001,276 ( 37 ) :34743 - 34752.
10Mototsugu O, Masafumi O, Atsushi T, et al. Constitutive activation of nuclear factor-κB prevents TRAIL-induced apoptosis in renal cancer cells[ J]. Oncogene,2001,20( 29 ) :3888 - 3896.
2Ambrosini G,Adida C,Altieri D. A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma[J]. Nat Med,1997,(8):917-21.
3Nasu S,Yagihashi A,Izawa A,et al. Survivin mRNA expression in patients breast cancer [J]. Anticancer Res,2002,22(3):1839-43.
4Kawasaki H,Toyoda M,Shinohara H,et al. Expression of survivin correlates with apoptosis,proliferation,and angiogenesis during human colorectal tumorigenesis[J]. Cancer,2001,91(11):2026-32.
5Chakravarti A,Noll E,Block PM, et al. Quantitatively determined survivin expression level are of prognotic value in human gliomas[J]. J Clin Oncol,2002,20(4):1063-8.
6Jaffe ES,Harris NL,Stein H,et al. WHO classification of tumors: Pathology and genetics of tumors of haematopoietic and lymphoid tissues[M]. Lyon:IARC Press ,2001:109-253.
7Adida C,Haioun C,Gaulard P, et al. Prognosis significance of survivin expression in diffuse large B-cell lymphoma[J]. Blood,2000,96(5):1921-5.
8Gradilone A,Gazzaniga P,Ribuffo,et al. Survivin,bcl-2,bax,and bcl-X gene expression in sentinel lymph nodes from melanoma patients[J]. J Clin Oncol,2003,21(2):305-12.
9Jaffe E S,Harris N L,Stein H,Vardiman J W.World Health Organization classification of tumours.Pathology and genetics of tumours of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2001:169.
10Tamm I,Wang Y,Sausville E,et al.IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas(CD95),bax,caspases,and anticancer drugs[J].Cancer Res,1998,58(23):5315-5320.
2Mouzakiti A,Paekham G. Regulation of Tumour Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis in Burkitt's Lymphoma Cell Lines[J]. Br J Haematol, 2003,122(1):61-69.
3Yang X,Thiele C J. Targeting the Tumor Necrosis Factor-related Apoptosis-inducing Ligand Path in Neuroblastoma[J]. Ca ncer Lett,2003,197(1/2) : 137-143.
4Evdokiou A,Bouralexis S, Atkins G J, et al. Chemotherapeutic Agents Sensitize Osteogenic Sarcoma Cells, but Not Normal Human Bone Cells, to Apo2L/TRAIL-induced Apoptosis[J]. Int J Cancer,2002,99(4) :491-504.
5Griffith T S, Anderson R D, Davidson B L, et al. Adenoviralmediated Transfer of the TNF-related Apoptosis-inducing Lig- and/Apo-2 Ligand Gene Induces Tumor Cell Apoptosis[J]. J Immunol, 2000,165(5) : 2886-2894.
6Nesterov A, Lu X, Johnson M, et al. Elevated AKT Activity Protects the Prostate Cancer Cell Line LNCaP from TRAIL-induced Apoptosis[J]. J Biol Chem, 2001,276 (14) : 10767-10774.
7Tafuku S, Matsuda T, Kawakami H, et al. Potential Mechanism of Resistance to TRAIL-induced Apoptosis in Burkitt's Lymphoma[J]. Eur J Haematol, 2006,76 (1) : 64-74.
8Ehrhardt H,Fulds S,Schmid I,et al. TRAIL Induced Survival and Proliferation in Cancer Calls Resistant Towards TRAIL-induced Apoptosis Mediated by NF-kappaB[J]. Oncogene, 2003,22(25): 3842-3852.
9Guo H Q, Huang G L, Guo C C, et al. Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma [ J ]. Dis Markers, 2010,29 ( 5 ) :251 - 8.
10Yang Q P, Zhang W Y, Yu J B, et al. Subtype distribution of lymphomas in Southwest China WHO classification in a single 2011,22(6) :77 -84.
